Beth Israel Deaconess Medical Center
We had to initiate emergency use protocol for one of our very first patients. It started on weekend. We came in and helped our medical team to initiate remdesivir treatment for this trial.
I am proud to say to date, we activated 13 SARS-CoV-2 clinical trials and enrolled upwards of 141 patients.
Heena Patel, RPH, is manager of the Research Pharmacy Department at Beth Israel Deaconess Medical Center.
Posted July 21, 2020